Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Regulatory News (TYR)

  • There is currently no data for TYR

Trading Update

22 Sep 2008 07:00

RNS Number : 9263D
TyraTech, Inc.
22 September 2008
Β 

ο»Ώ

For immediate release

22Β September 2008

TYRATECH, INC.

("TyraTech" or "the Company")

Trading UpdateΒ 

TyraTech, Inc. (AIM: TYR), a leading independent novel pesticide company for human, animal and environmental health, today announces an update on trading.

TyraTech's commercial programmes are progressing well. However, due to the lengthy nature of commercial discussions with partners and customers, as well as TyraTech's disciplined approach to partner selection and deal negotiation, the Board anticipates that revenues and profits for the full year 2008 are unlikely to meet with current market expectations. The Company does, however, expect to report on positive progress from sales and partnership discussions before year end.

Revenue generating products and near term cash flowsΒ 

TyraTech's lead insecticide product, Naturalsβ„’ Crawling Insect Killer, has enjoyed growth in distribution outlets in theΒ USΒ via own label sales and a local distribution partner, SYSCO.

TyraTech's WasteSolver business is progressing well as evidenced by the growing customer pipeline and receipt of four signed orders plus a further four signed letters of intent. While sales of this product have been initially slower than expected due to the extended sales lead time necessary for farmers to evaluate the new waste management solution, customer feedback and the current order book confirm management's confidence in this product line.

Partnerships and milestones

TyraTech has diversified revenue streams which combine strong relationships with blue-chip partners and direct sales. The Company is actively involved in several partnership discussions with new partners covering consumer products, agriculture andΒ animal health, and has a signedΒ letter of intent in place with one significantΒ USΒ business for one of these key markets. The Board of TyraTech expects positive commercial progress and newsflow in the near to medium term on these discussions. However, despite real progress, signatures and timing of new partnerships and product launches have proved difficult to predict. In addition, whilst TyraTech reports that existing partner development programmes are progressing well, related milestones are now not expected until H1 2009.

Financials

The Company will announce its interim results onΒ 26 September 2008Β where revenue for the first half of the year is anticipated to be approximately $2.4 million with an operating loss of $9.8 million. The cash balance at the end of June 2008 was $14.9 million which the Board expects to be sufficient for the Company's current operations.Β 

Based on recent progress in the pipeline, work with current and future partners and new scheduled product releases, TyraTech expects to report strong growth in 2009. The Company's revenues are also expected to continue growing throughout H2 2008.

Commenting on the announcement, Douglas Armstrong Ph.D., Chief Executive Officer of TyraTech, said:Β "TyraTech has a diversified business model with revenue potentially arising from a number of different sources. We continue to receive strong feedback from our customers, and have made progress across all markets. We are therefore confident we can deliver successfully on our current and new potential partnerships.

"While the business operations have progressed well, we have been disappointed at the speed of entry into certain markets. As a management team we remain positive that we can execute our business plan and strategy and that there is potential for high gross margins on products and up front and milestone payments from partnering and licensing deals. We trust to be able to evidence this progress through announcements for the rest of 2008 which will have a positive impact on 2009 revenues."

For further information please contact:

TyraTech Inc.

Keith Bigsby, Chief Financial Officer +1 (321) 409 7714

www.tyratech.com

Nomura Code Securities

Charles Walker +44 (0)20 7776 1200

www.nomuracode.com

Buchanan Communications

Maryί›Jane Johnson / Lisa Baderoon / Catherine Breen +44 (0) 20 7466 5000

About TyraTech

TyraTech was formed in 2004 to develop and commercialise products for the control of invertebrate pests and pathogens using the Company’s proprietary technology. TyraTech, which already has a product on the market, is positioned for human health, animal health and pesticide market opportunities which total over $23 billion globally.Β TyraTech’s technology provides the Company with a wide variety of product and business opportunities in many markets and geographic regions. The differentiating feature of these products is the potential to have a combined level of potency and safety that other invertebrate control products are unable to offer. TyraTech’s platform brings many of the principles of drug discovery and development to the fields of insecticides and parasiticides. By targeting specific chemoreceptors that are found in invertebrates but not in humans and animals, TyraTech can produce products that use natural plant derived compounds targeting these receptors.

TyraTech's plan for the use of its technology is to develop selected proprietary active ingredients which can then be used across a wide variety of market segments, either by development partners or by TyraTech itself. TyraTech already has products or partnerships in the areas of professional and horticultural insect control, and for an insect/mosquito repellent. TyraTech also has an innovative partnership with Kraft to use its natural oils to develop functional foods for improving the health of the more than 2 billion people worldwide subject to intestinal parasitic infections.

TyraTech also has a separate technology with associated intellectual property that is the basis for the Sustainable Solutions business. This technology has been incorporated into specialised dairy farm equipment for processing cattle manure waste to a usable material for TyraTech to sell as a commercial plant growing medium. For more information please visit www.tyratech.com.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTPUUAPBUPRGRG
Date   Source Headline
24th Sep 20157:00 amRNSHalf Yearly Report
2nd Sep 20157:00 amRNSMigration of shares
6th Aug 20157:00 amRNSMigration of Shares
30th Jul 20154:38 pmRNSResult of AGM
3rd Jul 20155:04 pmRNSMigration of Shares
22nd Jun 20157:00 amRNSFinal Results
10th Jun 20152:22 pmRNSMigration of Shares
26th May 20157:01 amRNSSmartPak launches OutSmart insect repellent
21st May 20155:45 pmRNSMigration of Shares
22nd Apr 20157:00 amRNSDirector's Dealings
20th Apr 20157:00 amRNSEnvance LLC amended: Sharpened strategic focus
9th Apr 20151:14 pmRNSMigration of Shares
8th Apr 20157:00 amRNSListing with Walgreens in the USA
27th Mar 20159:41 amRNSMigration of Shares and Exercise of SARs
25th Mar 20157:00 amRNSVamousse now distributed by CVS in the USA
3rd Mar 20157:00 amRNSVamousse now listed by the top 3 distributors, USA
25th Feb 20157:00 amRNSLloyds and Day Lewis Pharmacy listings
16th Feb 20155:01 pmRNSDirector's Dealings
2nd Feb 20157:00 amRNSVamousse at Walmart and Cardinal Health USA
26th Jan 20157:00 amRNSInnovators and Investors Forum, London
15th Jan 20157:00 amRNSAppointment of Chief Financial Officer & Treasurer
2nd Dec 20147:00 amRNSTrading Update
1st Oct 20147:00 amRNSExercise of Warrants
29th Sep 20147:00 amRNSInterim Results
27th Aug 20147:00 amRNSVamousse products coming to Sainsbury's and Tesco
8th Aug 201410:30 amRNSHolding(s) in Company
5th Aug 201410:29 amRNSHolding(s) in Company
1st Aug 20145:49 pmRNSHolding(s) in Company
1st Aug 20142:40 pmRNSHolding(s) in Company
28th Jul 20145:35 pmRNSResult of Special Meeting & Director Shareholdings
16th Jul 20147:00 amRNSResult of AGM
16th Jul 20147:00 amRNSPlacing to raise £3.5m and launch of UK Vamousse
26th Jun 20147:00 amRNSFinal Results
22nd May 20144:02 pmRNSMigration of Shares
19th May 20146:15 pmRNSMigration of Shares
19th May 20147:00 amRNSVamousse product line available online across USA
30th Apr 20147:00 amRNSNatunex product launched across USA
24th Apr 20147:00 amRNSUSA Pest Control Patents Secured
8th Apr 20146:10 pmRNSDirector's Dealings
7th Apr 20144:41 pmRNSDirector's Dealings
1st Apr 20147:00 amRNSVamousse at over 4,000 Walmart Stores in USA
7th Mar 20147:00 amRNSMigration of Shares
6th Mar 201411:48 amRNSHolding(s) in Company
6th Mar 20147:00 amRNSAward of Share Options
24th Feb 20147:00 amRNSProposed Migration of Shares
18th Feb 20143:38 pmRNSResult of Special Meeting
13th Feb 20149:47 amRNSHolding(s) in Company
31st Jan 20144:26 pmRNSProposed Placing
23rd Jan 20145:58 pmRNSHolding(s) in Company
20th Jan 20147:00 amRNSHead-Lice Preventative Shampoo Coming to US Market

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.